Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 8 Neoplasms 6 Hypogonadism 2 Testicular Neoplasms 1 Sexuality 1 Osteoporosis 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Fatigue 1 Eunuchism 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Arthralgia 1

Interventions

Modafinil 9 Methylphenidate 4 Saline Solution 3 regorafenib 2 Sugars 2 Physical Therapy Modalities 2 Exercise 2 Dexamethasone 2 reparixin 1 ofatumumab 1 epoetin beta 1 eicosapentaenoic acid ethyl ester 1 eicosapentaenoic acid ethanolamide 1 clazakizumab 1 caffeine, sodium benzoate drug combination 1 Yoga 1 Walking 1 Waiting Lists 1 Vinorelbine 1 Urinalysis 1 Therapeutics 1 Thalidomide 1 Testosterone 1 Sodium Chloride 1 Proton Pump Inhibitors 1 Patient Reported Outcome Measures 1 Megestrol Acetate 1 Lenalidomide 1 Lactose 1 Infliximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fatigue × Testosterone × Clear all

NCT04301765 2026-03-31

TEMEC

Seattle Institute for Biomedical and Clinical Research

Phase 2 Recruiting

Eunuchism, Fatigue, Hypogonadism, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡